isoguvacine has been researched along with neuropeptide y in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Koning, HP; Jenks, BG; Leenders, HJ; Ponten, SP; Roubos, EW | 1 |
| Cruijsen, PM; Dotman, CH; Jenks, BG; Roubos, EW | 1 |
2 other study(ies) available for isoguvacine and neuropeptide y
| Article | Year |
|---|---|
Differential effects of coexisting dopamine, GABA and NPY on alpha-MSH secretion from melanotrope cells of Xenopus laevis.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; alpha-MSH; Animals; Baclofen; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; In Vitro Techniques; Isonicotinic Acids; Kinetics; Neuropeptide Y; Perfusion; Pituitary Gland; Radioimmunoassay; Xenopus laevis | 1993 |
Differential action of secreto-inhibitors on proopiomelanocortin biosynthesis in the intermediate pituitary of Xenopus laevis.
Topics: alpha-MSH; Analysis of Variance; Animals; Apomorphine; Baclofen; GABA Agonists; GABA-A Receptor Agonists; GABA-B Receptor Agonists; In Vitro Techniques; Isonicotinic Acids; Kinetics; Neuropeptide Y; Pituitary Gland; Pro-Opiomelanocortin; Receptors, Dopamine D2; Xenopus laevis | 1996 |